Jyong Biotech Eyes Vietnam Expansion Amid Volatile Stock, Plant‑Based Urinary Treatments Lead the Way
Jyong Biotech’s plant‑derived urinary therapies and Vietnam expansion signal growth, but stock volatility and negative valuation warn investors to watch closely.
2 minutes to read